Skip to main content
SpringerLink
Log in

Special Population: Adults with Severe and Persistent Mental Health Disorders

  • Chapter
  • First Online:
Chronic Illness Care

  • 683 Accesses

Abstract

Serious mental illness (SMI) encompasses a variety of diagnoses including schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Individuals with SMI have impaired global functioning and suffer from higher levels of morbidity and mortality compared with the general population, in large part due to comorbid physical illness. Individuals with SMI require intensive multidisciplinary care from the medical professions as well as social and community supports. A whole-person approach integrating mental and physical health care improves quality of life, functioning, and health outcomes. Providing quality care to these patients depends on high performing and compassionate care team members, payment models that account for complexity, innovative service models that improve access, and community engagement to reduce the stigma associated with psychiatric illness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Recommendations based on a 2004 consensus statement by the American Diabetes Association, the American Psychiatric Association, the American Association of Clinical Endocrinologists, and the North American Association for the Study of Obesity [36]. It is augmented by more recent European guidelines calling for more frequent glucose and lipid monitoring [26].

References

  1. National Institutes of Mental Health. NIMH: mental illness. 2019. https://www.nimh.nih.gov/health/statistics/mental-illness. Accessed 16 Nov 2021.

  2. SAMHSA National Registry of Evidence-Based Programs and Practices (NREPP). Behind the term: serious mental illness. 2016. https://www.hsdl.org/?view&did=801613. Accessed 14 Nov 2021.

  3. Daumit GL, Anthony CB, Ford DE, et al. Pattern of mortality in a sample of Maryland residents with severe mental illness. Psychiatry Res. 2010;176(2–3):242–5. https://doi.org/10.1016/j.psychres.2009.01.006.

    Article  PubMed  PubMed Central  Google Scholar 

  4. de Mooij LD, Kikkert M, Theunissen J, et al. Dying too soon: excess mortality in severe mental illness. Front Psychiatry. 2019;10:855. https://doi.org/10.3389/fpsyt.2019.00855.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011;49(6):599–604. https://doi.org/10.1097/MLR.0b013e31820bf86e.

    Article  PubMed  Google Scholar 

  6. Walker ER, Cummings JR, Hockenberry JM, Druss BG. Insurance status, use of mental health services, and unmet need for mental health care in the United States. Psychiatr Serv. 2015;66(6):578–84. https://doi.org/10.1176/appi.ps.201400248.

    Article  PubMed  PubMed Central  Google Scholar 

  7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition: DSM-5. 5th ed. American Psychiatric Publishing; 1980. p. 991.

    Google Scholar 

  8. Griswold KS, Del Regno PA, Berger RC. Recognition and differential diagnosis of psychosis in primary care. Am Fam Physician. 2015;91(12):856–63.

    PubMed  Google Scholar 

  9. Nevarez-Flores AG, Sanderson K, Breslin M, Carr VJ, Morgan VA, Neil AL. Systematic review of global functioning and quality of life in people with psychotic disorders. Epidemiol Psychiatr Sci. 2019;28(1):31–44. https://doi.org/10.1017/S2045796018000549.

    Article  CAS  PubMed  Google Scholar 

  10. Saarni SI, Viertiö S, Perälä J, Koskinen S, Lönnqvist J, Suvisaari J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry. 2010;197(5):386–94. https://doi.org/10.1192/bjp.bp.109.076489.

    Article  PubMed  Google Scholar 

  11. Jin H, Mosweu I. The societal cost of schizophrenia: A systematic review. Pharmacoeconomics. 2017;35(1):25–42. https://doi.org/10.1007/s40273-016-0444-6.

    Article  PubMed  Google Scholar 

  12. Lieberman JA, First MB. Psychotic disorders. N Engl J Med. 2018;379(3):270–80. https://doi.org/10.1056/NEJMra1801490.

    Article  CAS  PubMed  Google Scholar 

  13. Zamanpoor M. Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatr Genet. 2020;30(1):1–9. https://doi.org/10.1097/YPG.0000000000000245.

    Article  PubMed  Google Scholar 

  14. van Os J, Kapur S. Schizophrenia. Lancet. 2009;374(9690):635–45. https://doi.org/10.1016/S0140-6736(09)60995-8.

    Article  CAS  PubMed  Google Scholar 

  15. Schultz SK, Andreasen NC. Schizophrenia. Lancet. 1999;353(9162):1425–30. https://doi.org/10.1016/s0140-6736(98)07549-7.

    Article  CAS  PubMed  Google Scholar 

  16. Miller JN, Black DW. Schizoaffective disorder: a review. Ann Clin Psychiatry. 2019;31(1):47–53.

    Article  PubMed  Google Scholar 

  17. Anderson IM, Haddad PM, Scott J. Bipolar disorder. BMJ. 2012;345:e8508. https://doi.org/10.1136/bmj.e8508.

    Article  PubMed  Google Scholar 

  18. Benard V, Vaiva G, Masson M, Geoffroy PA. Lithium and suicide prevention in bipolar disorder. Encephale. 2016;42(3):234–41. https://doi.org/10.1016/j.encep.2016.02.006.

    Article  CAS  PubMed  Google Scholar 

  19. Uher R, Pallaskorpi S, Suominen K, Mantere O, Pavlova B, Isometsä E. Clinical course predicts long-term outcomes in bipolar disorder. Psychol Med. 2019;49(7):1109–17. https://doi.org/10.1017/S0033291718001678.

    Article  PubMed  Google Scholar 

  20. Tondo L, Vázquez GH, Baldessarini RJ. Depression and mania in bipolar disorder. Curr Neuropharmacol. 2017;15(3):353–8. https://doi.org/10.2174/1570159X14666160606210811.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. National Coalition for the Homeless. Mental illness and homelessness. Jul 2009. https://www.nationalhomeless.org/factsheets/Mental_Illness.pdf. Accessed 15 Nov 2021.

  22. Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006;86(1-3):15–22. https://doi.org/10.1016/j.schres.2006.06.026.

    Article  PubMed  Google Scholar 

  23. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24(6):412–24. https://doi.org/10.1016/j.eurpsy.2009.01.005.

    Article  PubMed  Google Scholar 

  24. Cobos B, Haskard-Zolnierek K, Howard K. White coat hypertension: improving the patient-health care practitioner relationship. Psychol Res Behav Manag. 2015;8:133–41. https://doi.org/10.2147/PRBM.S61192.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Finley PR. Drug interactions with lithium: an update. Clin Pharmacokinet. 2016;55(8):925–41. https://doi.org/10.1007/s40262-016-0370-y.

    Article  CAS  PubMed  Google Scholar 

  26. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011;8(2):114–26. https://doi.org/10.1038/nrendo.2011.156.

    Article  CAS  PubMed  Google Scholar 

  27. Glassman AH, Bigger JT. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158(11):1774–82. https://doi.org/10.1176/appi.ajp.158.11.1774.

    Article  CAS  PubMed  Google Scholar 

  28. Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015;72(12):1172–81. https://doi.org/10.1001/jamapsychiatry.2015.1737.

    Article  PubMed  Google Scholar 

  29. Pillinger T, McCutcheon RA, Vano L, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(1):64–77. https://doi.org/10.1016/S2215-0366(19)30416-X.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Vancampfort D, Stubbs B, Mitchell AJ, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339–47. https://doi.org/10.1002/wps.20252.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620–7. https://doi.org/10.1016/S0140-6736(09)60742-X.

    Article  PubMed  Google Scholar 

  32. Allison DB, Newcomer JW, Dunn AL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009;36(4):341–50. https://doi.org/10.1016/j.amepre.2008.11.020.

    Article  PubMed  Google Scholar 

  33. Cabassa LJ, Ezell JM, Lewis-Fernández R. Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatr Serv. 2010;61(8):774–82. https://doi.org/10.1176/ps.2010.61.8.774.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Calkin CV, Gardner DM, Ransom T, Alda M. The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann Med. 2013;45(2):171–81. https://doi.org/10.3109/07853890.2012.687835.

    Article  CAS  PubMed  Google Scholar 

  35. Bellivier F. Schizophrenia, antipsychotics and diabetes: genetic aspects. Eur Psychiatry. 2005;20(Suppl 4):S335–9. https://doi.org/10.1016/s0924-9338(05)80187-7.

    Article  PubMed  Google Scholar 

  36. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596–601. https://doi.org/10.2337/diacare.27.2.596.

    Article  Google Scholar 

  37. Jarskog LF, Yu R. Modifiable risk factors for cardiovascular disease in patients with severe mental illness. UpToDate; 2021.

    Google Scholar 

  38. Jackson JG, Diaz FJ, Lopez L, de Leon J. A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disord. 2015;17(6):575–97. https://doi.org/10.1111/bdi.12319.

    Article  PubMed  Google Scholar 

  39. Lising-Enriquez K, George TP. Treatment of comorbid tobacco use in people with serious mental illness. J Psychiatry Neurosci. 2009;34(3):E1–2.

    PubMed  PubMed Central  Google Scholar 

  40. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–20. https://doi.org/10.1016/S0140-6736(16)30272-0.

    Article  CAS  PubMed  Google Scholar 

  41. Evins AE, Cather C, Laffer A. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry. 2015;23(2):90–8. https://doi.org/10.1097/HRP.0000000000000063.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Roberts E, Eden Evins A, McNeill A, Robson D. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction. 2016;111(4):599–612. https://doi.org/10.1111/add.13236.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Hartz SM, Pato CN, Medeiros H, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71(3):248–54. https://doi.org/10.1001/jamapsychiatry.2013.3726.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Green AI, Drake RE, Brunette MF, Noordsy DL. Schizophrenia and co-occurring substance use disorder. Am J Psychiatry. 2007;164(3):402–8. https://doi.org/10.1176/ajp.2007.164.3.402.

    Article  PubMed  Google Scholar 

  45. Li KJ, Chen A, DeLisi LE. Opioid use and schizophrenia. Curr Opin Psychiatry. 2020;33(3):219–24. https://doi.org/10.1097/YCO.0000000000000593.

    Article  PubMed  Google Scholar 

  46. Robertson AG, Easter MM, Lin H, Frisman LK, Swanson JW, Swartz MS. Medication-assisted treatment for alcohol-dependent adults with serious mental illness and criminal justice involvement: effects on treatment utilization and outcomes. Am J Psychiatry. 2018;175(7):665–73. https://doi.org/10.1176/appi.ajp.2018.17060688.

    Article  PubMed  PubMed Central  Google Scholar 

  47. About Intellectual and Developmental Disabilities (IDDs) | NICHD—Eunice Kennedy Shriver National Institute of Child Health and Human Development. https://www.nichd.nih.gov/health/topics/idds/conditioninfo. Accessed 4 Mar 2022.

  48. Munir KM. The co-occurrence of mental disorders in children and adolescents with intellectual disability/intellectual developmental disorder. Curr Opin Psychiatry. 2016;29(2):95–102. https://doi.org/10.1097/YCO.0000000000000236.

    Article  PubMed  PubMed Central  Google Scholar 

  49. About L’Arche USA | Communities for Intellectual Disabilities. https://www.larcheusa.org/about/. Accessed 4 Mar 2022.

  50. Traumatic Brain Injury Information Page | National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/Disorders/All-Disorders/Traumatic-Brain-Injury-Information-Page. Accessed 4 Mar 2022.

  51. Fujii DE, Ahmed I. Psychotic disorder caused by traumatic brain injury. Psychiatr Clin North Am. 2014;37(1):113–24. https://doi.org/10.1016/j.psc.2013.11.006.

    Article  PubMed  Google Scholar 

  52. Press D. Management of neuropsychiatric symptoms of dementia. UpToDate; 2020.

    Google Scholar 

  53. American Geriatrics Society. American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.

    Article  Google Scholar 

  54. Steiner BD, Wahrenberger JT, Raney L. Providing effective primary care for patients with serious mental illness: additional components to enhance practice. Community Ment Health J. 2020;56(4):592–6. https://doi.org/10.1007/s10597-019-00517-2.

    Article  PubMed  Google Scholar 

  55. Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies. Lancet Psychiatry. 2021;6 https://doi.org/10.1016/S2215-0366(21)00039-0.

  56. Pacchiarotti I, Tiihonen J, Kotzalidis GD, et al. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: a systematic review. Eur Neuropsychopharmacol. 2019;29(4):457–70. https://doi.org/10.1016/j.euroneuro.2019.02.003.

    Article  CAS  PubMed  Google Scholar 

  57. Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939–51. https://doi.org/10.1016/S0140-6736(19)31135-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868–72. https://doi.org/10.1176/appi.ajp.2020.177901.

    Article  PubMed  Google Scholar 

  59. Stroup TS, Marder S. Schizophrenia in adults: Maintenance therapy and side effect management—UpToDate. https://www.uptodate.com/contents/schizophrenia-in-adults-maintenance-therapy-and-side-effect-management?search=acute%20dystonia&sectionRank=1&usage_type=default&anchor=H2486805191&source=machineLearning&selectedTitle=3~110&display_rank=3#H2486805191. Accessed 4 Mar 2022.

  60. Canuso CM, Schooler N, Carothers J, et al. Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers. J Clin Psychopharmacol. 2010;30(5):487–95. https://doi.org/10.1097/JCP.0b013e3181eeb600.

    Article  CAS  PubMed  Google Scholar 

  61. Lindenmayer J-P, Kaur A. Antipsychotic management of schizoaffective disorder: a review. Drugs. 2016;76(5):589–604. https://doi.org/10.1007/s40265-016-0551-x.

    Article  CAS  PubMed  Google Scholar 

  62. McGirr A, Vöhringer PA, Ghaemi SN, Lam RW, Yatham LN. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry. 2016;3(12):1138–46. https://doi.org/10.1016/S2215-0366(16)30264-4.

    Article  PubMed  Google Scholar 

  63. Dean OM, Gliddon E, Van Rheenen TE, et al. An update on adjunctive treatment options for bipolar disorder. Bipolar Disord. 2018;20(2):87–96. https://doi.org/10.1111/bdi.12601.

    Article  PubMed  Google Scholar 

  64. MacQueen GM, Young LT. Bipolar II disorder: symptoms, course, and response to treatment. Psychiatr Serv. 2001;52(3):358–61. https://doi.org/10.1176/appi.ps.52.3.358.

    Article  CAS  PubMed  Google Scholar 

  65. Jones C, Hacker D, Meaden A, et al. Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. Cochrane Database Syst Rev. 2018;11:CD008712. https://doi.org/10.1002/14651858.CD008712.pub3.

    Article  PubMed  Google Scholar 

  66. Summary E. Treatment for bipolar disorder in adults: a systematic review.

    Google Scholar 

  67. Etlouba Y, Laher A, Motara F, Moolla M, Ariefdien N. First presentation with psychotic symptoms to the emergency department. J Emerg Med. 2018;55(1):78–86. https://doi.org/10.1016/j.jemermed.2018.04.014.

    Article  PubMed  Google Scholar 

  68. Bahji A, Altomare J, Sapru A, Haze S, Prasad S, Egan R. Predictors of hospital admission for patients presenting with psychiatric emergencies: a retrospective, cohort study. Psychiatry Res. 2020;290:113149. https://doi.org/10.1016/j.psychres.2020.113149.

    Article  PubMed  Google Scholar 

  69. Murphy SM, Irving CB, Adams CE, Waqar M. Crisis intervention for people with severe mental illnesses. Cochrane Database Syst Rev. 2015;(12):CD001087. https://doi.org/10.1002/14651858.CD001087.pub5.

  70. Heath B Jr, Reynolds K, Romero PW. A standard framework for levels of integrated healthcare. SAMSHA-HRSA Center for Integrated Health Solutions; 2013.

    Google Scholar 

  71. Belson C, Sheitman B, Steiner B. The effects of an enhanced primary care model for patients with serious mental illness on emergency department utilization. Community Ment Health J. 2020;56(7):1311–7. https://doi.org/10.1007/s10597-020-00645-0.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Grove LR, Gertner AK, Swietek KE, et al. Effect of enhanced primary care for people with serious mental illness on service use and screening. J Gen Intern Med. 2021;36(4):970–7. https://doi.org/10.1007/s11606-020-06429-2.

    Article  PubMed  PubMed Central  Google Scholar 

  73. U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration. Building your program: assertive community treatment. https://store.samhsa.gov/sites/default/files/d7/priv/buildingyourprogram-act_1.pdf. Accessed 2 Mar 2022.

  74. Morse G, Monroe-DeVita M, York MM, et al. Implementing illness management and recovery within assertive community treatment teams: a qualitative study. Psychiatr Rehabil J. 2020;43(2):121–31. https://doi.org/10.1037/prj0000387.

    Article  PubMed  Google Scholar 

  75. Dieterich M, Irving CB, Bergman H, Khokhar MA, Park B, Marshall M. Intensive case management for severe mental illness. Cochrane Database Syst Rev. 2017;1:CD007906. https://doi.org/10.1002/14651858.CD007906.pub3.

    Article  PubMed  Google Scholar 

  76. Community Mental Health Act. National Council. https://www.thenationalcouncil.org/about/national-mental-health-association/overview/community-mental-health-act/. Accessed 4 Mar 2022.

  77. Erickson B. Deinstitutionalization through optimism: the community mental health act of 1963. Am J Psychiatr Resid J. 2021;16(4):6–7. https://doi.org/10.1176/appi.ajp-rj.2021.160404.

    Article  Google Scholar 

  78. Assertive Community Treatment | NCDHHS. https://www.ncdhhs.gov/divisions/mental-health-developmental-disabilities-and-substance-abuse/adult-mental-health-services/assertive-community-treatment. Accessed 4 Mar 2022.

  79. Center for Medicare and Medicaid Services. What is a PRTF? http://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/CertificationandComplianc/Downloads/WhatisaPRTF.pdf. Accessed 4 Mar 2022.

  80. Psychiatric Hospitals | CMS. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/CertificationandComplianc/PsychHospitals. Accessed 4 Mar 2022.

  81. Involuntary commitment (assisted treatment) standards (50 states)—treatment advocacy center report. Mental Illness Policy Org. https://mentalillnesspolicy.org/national-studies/state-standards-involuntary-treatment.html. Accessed 4 Mar 2022.

  82. Chien WT, Clifton AV, Zhao S, Lui S. Peer support for people with schizophrenia or other serious mental illness. Cochrane Database Syst Rev. 2019;4:CD010880. https://doi.org/10.1002/14651858.CD010880.pub2.

    Article  PubMed  Google Scholar 

  83. An assessment of innovative models of peer support services in behavioral health to reduce preventable acute hospitalization and readmissions. Published online 30 Nov 2015.

    Google Scholar 

  84. Bogucki OE, Williams MD, Solberg LI, Rossom RC, Sawchuk CN. The role of the patient-centered medical home in treating depression. Curr Psychiatry Rep. 2020;22(9):47. https://doi.org/10.1007/s11920-020-01167-y.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Unützer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836–45. https://doi.org/10.1001/jama.288.22.2836.

    Article  PubMed  Google Scholar 

  86. Perrin J, Reimann B, Capobianco J, Wahrenberger JT, Sheitman BB, Steiner BD. A model of enhanced primary care for patients with severe mental illness. N C Med J. 2018;79(4):240–4. https://doi.org/10.18043/ncm.79.4.240.

    Article  PubMed  Google Scholar 

  87. Substance Abuse and Mental Health Services Administration. Behavioral health workforce report. Substance Abuse and Mental Health Services Administration; 2021. https://annapoliscoalition.org/wp-content/uploads/2021/03/behavioral-health-workforce-report-SAMHSA-2.pdf. Accessed 4 Mar 2022.

  88. Abrams Z. New hope for people with serious mental illness. Monit Psychol. 2019;50(11). https://www.apa.org/monitor/2019/12/new-hope#. Accessed 4 Mar 2022.

  89. Santesteban-Echarri O, Piskulic D, Nyman RK, Addington J. Telehealth interventions for schizophrenia-spectrum disorders and clinical high-risk for psychosis individuals: a scoping review. J Telemed Telecare. 2020;26(1–2):14–20. https://doi.org/10.1177/1357633X18794100.

    Article  PubMed  Google Scholar 

  90. Kasckow J, Felmet K, Appelt C, Thompson R, Rotondi A, Haas G. Telepsychiatry in the assessment and treatment of schizophrenia. Clin Schizophr Relat Psychoses. 2014;8(1):21–27A. https://doi.org/10.3371/CSRP.KAFE.021513.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Cabassa LJ, Camacho D, Vélez-Grau CM, Stefancic A. Peer-based health interventions for people with serious mental illness: a systematic literature review. J Psychiatr Res. 2017;84:80–9. https://doi.org/10.1016/j.jpsychires.2016.09.021.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Kathleen Barnhouse, Sandra Clark & Jessica Waters Davis

  2. Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Sandra Clark & Jessica Waters Davis

Authors
  1. Kathleen Barnhouse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandra Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessica Waters Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathleen Barnhouse .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of North Carolina, CHAPEL HILL, NC, USA

    Timothy P. Daaleman

  2. Department of Family Medicine, University of North Carolina, CHAPEL HILL, NC, USA

    Margaret R. Helton

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Barnhouse, K., Clark, S., Waters Davis, J. (2023). Special Population: Adults with Severe and Persistent Mental Health Disorders. In: Daaleman, T.P., Helton, M.R. (eds) Chronic Illness Care. Springer, Cham. https://doi.org/10.1007/978-3-031-29171-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-29171-5_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-29170-8

  • Online ISBN: 978-3-031-29171-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation